» Articles » PMID: 23267668

Additional Risk Factors for Infection by Multidrug-resistant Pathogens in Healthcare-associated Infection: a Large Cohort Study

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2012 Dec 27
PMID 23267668
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a lack of consensus regarding the definition of risk factors for healthcare-associated infection (HCAI). The purpose of this study was to identify additional risk factors for HCAI, which are not included in the current definition of HCAI, associated with infection by multidrug-resistant (MDR) pathogens, in all hospitalized infected patients from the community.

Methods: This 1-year prospective cohort study included all patients with infection admitted to a large, tertiary care, university hospital. Risk factors not included in the HCAI definition, and independently associated with MDR pathogen infection, namely MDR Gram-negative (MDR-GN) and ESKAPE microorganisms (vancomycin-resistant Enterococcus faecium, methicillin-resistant Staphylococcus aureus, extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species, carbapenem-hydrolyzing Klebsiella pneumonia and MDR Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species), were identified by logistic regression among patients admitted from the community (either with community-acquired or HCAI).

Results: There were 1035 patients with infection, 718 from the community. Of these, 439 (61%) had microbiologic documentation; 123 were MDR (28%). Among MDR: 104 (85%) had MDR-GN and 41 (33%) had an ESKAPE infection. Independent risk factors associated with MDR and MDR-GN infection were: age (adjusted odds ratio (OR) = 1.7 and 1.5, p = 0.001 and p = 0.009, respectively), and hospitalization in the previous year (between 4 and 12 months previously) (adjusted OR = 2.0 and 1,7, p = 0.008 and p = 0.048, respectively). Infection by pathogens from the ESKAPE group was independently associated with previous antibiotic therapy (adjusted OR = 7.2, p < 0.001) and a Karnofsky index <70 (adjusted OR = 3.7, p = 0.003). Patients with infection by MDR, MDR-GN and pathogens from the ESKAPE group had significantly higher rates of inadequate antibiotic therapy than those without (46% vs 7%, 44% vs 10%, 61% vs 15%, respectively, p < 0.001).

Conclusions: This study suggests that the inclusion of additional risk factors in the current definition of HCAI for MDR pathogen infection, namely age >60 years, Karnofsky index <70, hospitalization in the previous year, and previous antibiotic therapy, may be clinically beneficial for early diagnosis, which may decrease the rate of inadequate antibiotic therapy among these patients.

Citing Articles

Evaluating Anti- Potential of . Extract against Healthcare-Associated Infections in Tertiary Hospitals of Al-Kharj Governorate: An Study.

Khan M, Bari M J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4649-S4654.

PMID: 40061695 PMC: 11888659. DOI: 10.4103/jpbs.jpbs_1253_24.


A machine-learning model for prediction of Acinetobacter baumannii hospital acquired infection.

Neuman I, Shvartser L, Teppler S, Friedman Y, Levine J, Kagan I PLoS One. 2024; 19(12):e0311576.

PMID: 39636870 PMC: 11620386. DOI: 10.1371/journal.pone.0311576.


Plasmid-mediated quinolone resistance determinants in clinical bacterial pathogens isolated from the Western Region of Ghana: a cross-sectional study.

Sah A, Feglo P Pan Afr Med J. 2023; 43:207.

PMID: 36942137 PMC: 10024564. DOI: 10.11604/pamj.2022.43.207.33734.


In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens.

Pi H, Venter H, Russell C, Young K, McCluskey A, Page S Antibiotics (Basel). 2022; 11(10).

PMID: 36289959 PMC: 9598656. DOI: 10.3390/antibiotics11101301.


Use of Contact Networks to Estimate Potential Pathogen Risk Exposure in Hospitals.

Madhobi K, Kalyanaraman A, Anderson D, Ashley E, Moehring R, Lofgren E JAMA Netw Open. 2022; 5(8):e2225508.

PMID: 35930285 PMC: 9356318. DOI: 10.1001/jamanetworkopen.2022.25508.


References
1.
Micek S, Kollef K, Reichley R, Roubinian N, Kollef M . Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007; 51(10):3568-73. PMC: 2043297. DOI: 10.1128/AAC.00851-07. View

2.
Garner J, Jarvis W, Emori T, Horan T, Hughes J . CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16(3):128-40. DOI: 10.1016/0196-6553(88)90053-3. View

3.
Carratala J, Mykietiuk A, Fernandez-Sabe N, Suarez C, Dorca J, Verdaguer R . Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007; 167(13):1393-9. DOI: 10.1001/archinte.167.13.1393. View

4.
Tambyah P, Habib A, Ng T, Goh H, Kumarasinghe G . Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated". Infect Control Hosp Epidemiol. 2003; 24(6):436-8. DOI: 10.1086/502228. View

5.
Brito V, Niederman M . Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis. 2009; 22(3):316-25. DOI: 10.1097/QCO.0b013e328329fa4e. View